Sign up to save your podcasts
Or
Share Conversations About PAH: Latest Developments and Key Insights for 2023 – Case Discussion
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Conversations About PAH: Latest Developments and Key Insights for 2023 – Case Discussion
CME credits: 0.75
Valid until: 21-06-2024
Claim your CME credit at https://reachmd.com/programs/cme/conversations-about-pah-latest-developments-and-key-insights-for-2023-case-discussion/15399/
Pulmonary arterial hypertension (PAH) is a chronic and progressive condition that affects the pulmonary vasculature, resulting in elevated pulmonary vascular resistance, right ventricular dysfunction, and eventually, right heart failure. It is essential to identify and manage PAH early to improve patient outcomes. This necessitates comprehensive knowledge of the diagnostic criteria and classification of PAH, as well as a care approach based on evidence that incorporates the latest guidelines, advancements, and recommendations from leading professional organizations. In addition, due to the inadequacies of current therapies, it is necessary to critically evaluate novel treatment pathways and new/emerging therapeutic targets for PAH.
In this clinical discussion, you'll hear from two leading experts who will discuss patient cases and discuss how you can optimize PAH treatment plans based on risk stratification and comorbidities and integrate the evidence-based recommendations and treatments in your practice.
=
View all episodes
By ReachMD
4.3
33 ratings
CME credits: 0.75
Valid until: 21-06-2024
Claim your CME credit at https://reachmd.com/programs/cme/conversations-about-pah-latest-developments-and-key-insights-for-2023-case-discussion/15399/
Pulmonary arterial hypertension (PAH) is a chronic and progressive condition that affects the pulmonary vasculature, resulting in elevated pulmonary vascular resistance, right ventricular dysfunction, and eventually, right heart failure. It is essential to identify and manage PAH early to improve patient outcomes. This necessitates comprehensive knowledge of the diagnostic criteria and classification of PAH, as well as a care approach based on evidence that incorporates the latest guidelines, advancements, and recommendations from leading professional organizations. In addition, due to the inadequacies of current therapies, it is necessary to critically evaluate novel treatment pathways and new/emerging therapeutic targets for PAH.
In this clinical discussion, you'll hear from two leading experts who will discuss patient cases and discuss how you can optimize PAH treatment plans based on risk stratification and comorbidities and integrate the evidence-based recommendations and treatments in your practice.
=